US pharmaceutical giant Pfizer signed a contract with the Croatian biotechnology company Genera Research to buy its patent rights for a drug that battles kidney problems.
Američki farmaceutski div Pfizer potpisao je s hrvatskom biotehnološkom tvrtkom Genera istraživanja ugovor o kupovini prava na patent za lijek koji se koristi u borbi s bolestima bubrega.